Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global In-Vitro Diagnostics Market: By Product and Service: Reagents and Kits, Instruments, Software and Services; By Technology: Immunodiagnostics, Clinical Chemistry, Others; By Application; By End Use; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global In-Vitro Diagnostics Market Outlook

The global in-vitro diagnostics market reached a value of about USD 63 billion in 2020. The market is further expected to grow at a CAGR of 4.5% in the forecast period of 2021-2026 to reach a value of approximately USD 82 billion by 2026.

 

Global In-Vitro Diagnostics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Demand for Point of Care Testing to Augment the In-Vitro Diagnostics Industry Growth

Based on end-use, the point of care (POC) testing segment accounts for a significant share in the in-vitro diagnostics industry. This can be attributed to the development of technology that has made POC testing seamless and quick, thus, making it the first choice of customers. Further, they shorten a 5 step traditional approach to a simple 2 step process, which makes the testing quick as well as cost-effective. The rising demand for convenience is significantly contributing to the growth of the segment.

 

The Asia Pacific to Provide Enhanced Growth Opportunities to the In-Vitro Diagnostics Industry

Region-wise, the Asia Pacific is expected to witness a steady growth over the forecast period owing to the increasing demand for advanced diagnostic facilities, improving healthcare infrastructure, and rising standard of living. Within Asia Pacific, China is one of the key markets for the product. Furthermore, medical inspection revenue has also increased in the region, which, in turn, is leading to an increased demand for IVD products.


In-Vitro Diagnostics: Industry Definition and Segmentation

In-vitro diagnostics (IVDs) refer to the medical tests performed on blood or tissue samples that have been taken from the human body. In-vitro diagnostics can detect diseases such as HIV and cholera and can be used to keep a check on a patient’s overall health to help cure, treat, or prevent diseases. In-vitro diagnostics are used to identify specific treatments that can give added benefits to patients over other treatments. Furthermore, with advancements in the field of in vitro diagnostics, there has been a growing focus on next-generation sequencing (NGS) tests, which can scan a person’s DNA to detect genomic variations.

 

Global In-Vitro Diagnostics Market By End Use

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By product and service, the market is divided into:

  • Reagents and Kits 
  • Instruments
  • Software and Services  

Based on technology, the industry can be segmented into:

  • Immunodiagnostics 
    • Enzyme-Linked Immunosorbent Assay (ELISA) 
    • Enzyme-Linked Immunospot (ELISPOT) 
    • Rapid Tests 
    • Radioimmunoassay (RIA) 
    • Western Blotting 
    • Others
  • Clinical Chemistry
    • Basic Metabolic Panels 
    • Liver Panels 
    • Renal Profiles 
    • Lipid Profiles 
    • Thyroid Function Panels 
    • Electrolyte Panels 
    • Specialty Chemical Tests 
    • Others 
  • Molecular Diagnostics 
    • Polymerize Chain Reaction (PCR) 
    • Isothermal Nucleic Acid Amplification Technology (INAAT) 
    • Hybridisation 
    • DNA diagnostics 
    • Microarray 
    • Others 
  • Haematology 
  • Microbiology 
  • Coagulation and Haemostasis 
  • Urinalysis 
  • Others 

The market is divided based on application into:

  • Infectious Diseases 
  • Diabetes 
  • Oncology   
  • Cardiology   
  • Drug Testing/Pharmacogenomics   
  • HIV/Aids
  • Autoimmune Diseases
  • Nephrology     
  • Others  

On the basis of end use, the industry can be categorised into:

  • Hospital and Clinics 
  • Diagnostic Laboratories 
  • Point-Of-Care Testing 
  • Academic Institutes 
  • Others   

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global In-Vitro Diagnostics Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Demand for Rapid Testing and the Rise in Prevalence of Chronic Diseases to Bolster the Growth of the In-Vitro Diagnostics Industry

In recent years, in-vitro diagnostics has witnessed a surge in demand owing to the incresaing demand for advanced diagnostic facilities and a dramatic shift towards rapid testing. There has been a rise in the adoption of in-vitro diagnostics like point of care testing, PCR testing, and DNA diagnostics. During times of COVID-19, rapid testing has emerged as the primary method of identifying infected people. Furthermore, the rise in the prevalence of chronic as well as lifestyle disorders is creating a huge market for the in-vitro diagnostics industry.

Over the forecast period, the rapid technological advancements and the increasing focus on safety and accuracy are expected to favour the industry growth. The rise in chronic diseases is expected to further propel the industry forward.  

 

Key Industry Players in the Global In-Vitro Diagnostics Market

The report gives a detailed analysis of the following key players in the global in-vitro diagnostics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Danaher Corp 
  • bioMérieux, Inc 
  • Siemens Healthcare GmbH  
  • ARKRAY America, Inc. 
  • Sysmex Corporation  
  • F. Hoffmann-La Roche Ltd 
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast
Market Analysis by Segment- Product and Service, Technology, Application, End Use, Region
Breakup by Product and Service Reagents and Kits, Instruments, Software and Services
Breakup by Technology Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Haematology,
Microbiology, Coagulation and Haemostasis, Urinalysis, Others
Breakup by Application Infectious Diseases, Diabetes, Oncology, Cardiology, Drug Testing/Pharmacogenomics,
HIV/Aids, Autoimmune Diseases, Nephrology, Others
Breakup by End Use Hospital and Clinics, Diagnostic Laboratories, Point-Of-Care Testing, Academic Institutes, Others
Breakup by Region North America, Latin America, Europe, Middle East and Africa, Asia Pacific
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio,
Demographic Reach and Achievements, Certifications
Companies Covered Danaher Corp, bioMérieux, Inc, Siemens Healthcare GmbH, ARKRAY America, Inc.,
Sysmex Corporation, F. Hoffmann-La Roche Ltd, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global In-Vitro Diagnostics Market Analysis

    8.1    Key Industry Highlights
    8.2    Global In-Vitro Diagnostics Historical Market (2016-2020) 
    8.3    Global In-Vitro Diagnostics Market Forecast (2021-2026)
    8.4    Global In-Vitro Diagnostics Market by Product and Service
        8.4.1    Reagents and Kits
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Instruments
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Software and Services
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
    8.5    Global In-Vitro Diagnostics Market by Technology
        8.5.1    Immunodiagnostics
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
            8.5.1.4    Breakup by Type
                8.5.1.4.1    Enzyme-Linked Immunosorbent Assay (ELISA)
                    8.5.1.4.1.1    Market Share
                    8.5.1.4.1.2    Historical Trend (2016-2020)
                    8.5.1.4.1.3    Forecast Trend (2021-2026)
                8.5.1.4.2    Enzyme-Linked Immunospot (ELISPOT)
                    8.5.1.4.2.1    Market Share
                    8.5.1.4.2.2    Historical Trend (2016-2020)
                    8.5.1.4.2.3    Forecast Trend (2021-2026)
                8.5.1.4.3    Rapid Tests
                    8.5.1.4.3.1    Market Share
                    8.5.1.4.3.2    Historical Trend (2016-2020)
                    8.5.1.4.3.3    Forecast Trend (2021-2026)
                8.5.1.4.4    Radioimmunoassay (RIA)
                    8.5.1.4.4.1    Market Share
                    8.5.1.4.4.2    Historical Trend (2016-2020)
                    8.5.1.4.4.3    Forecast Trend (2021-2026)
                8.5.1.4.5    Western Blotting
                    8.5.1.4.5.1    Market Share
                    8.5.1.4.5.2    Historical Trend (2016-2020)
                    8.5.1.4.5.3    Forecast Trend (2021-2026)
                8.5.1.4.6    Others
        8.5.2    Clinical Chemistry
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
            8.5.2.4    Breakup by Type
                8.5.2.4.1    Basic Metabolic Panels
                    8.5.2.4.1.1    Market Share
                    8.5.2.4.1.2    Historical Trend (2016-2020)
                    8.5.2.4.1.3    Forecast Trend (2021-2026)
                8.5.2.4.2    Liver Panels
                    8.5.2.4.2.1    Market Share
                    8.5.2.4.2.2    Historical Trend (2016-2020)
                    8.5.2.4.2.3    Forecast Trend (2021-2026)
                8.5.2.4.3    Renal Profiles
                    8.5.2.4.3.1    Market Share
                    8.5.2.4.3.2    Historical Trend (2016-2020)
                    8.5.2.4.3.3    Forecast Trend (2021-2026)
                8.5.2.4.4    Lipid Profiles
                    8.5.2.4.4.1    Market Share
                    8.5.2.4.4.2    Historical Trend (2016-2020)
                    8.5.2.4.4.3    Forecast Trend (2021-2026)
                8.5.2.4.5    Thyroid Function Panels
                    8.5.2.4.5.1    Market Share
                    8.5.2.4.5.2    Historical Trend (2016-2020)
                    8.5.2.4.5.3    Forecast Trend (2021-2026)
                8.5.2.4.6    Electrolyte Panels
                    8.5.2.4.6.1    Market Share
                    8.5.2.4.6.2    Historical Trend (2016-2020)
                    8.5.2.4.6.3    Forecast Trend (2021-2026)
                8.5.2.4.7    Specialty Chemical Tests
                    8.5.2.4.7.1    Market Share
                    8.5.2.4.7.2    Historical Trend (2016-2020)
                    8.5.2.4.7.3    Forecast Trend (2021-2026)
                8.5.2.4.8    Others
        8.5.3    Molecular Diagnostics
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
            8.5.3.4    Breakup by Type
                8.5.3.4.1    Polymerize Chain Reaction (PCR)
                    8.5.3.4.1.1    Market Share
                    8.5.3.4.1.2    Historical Trend (2016-2020)
                    8.5.3.4.1.3    Forecast Trend (2021-2026)
                8.5.3.4.2    Isothermal Nucleic Acid Amplification Technology (INAAT)
                    8.5.3.4.2.1    Market Share
                    8.5.3.4.2.2    Historical Trend (2016-2020)
                    8.5.3.4.2.3    Forecast Trend (2021-2026)
                8.5.3.4.3    Hybridisation
                    8.5.3.4.3.1    Market Share
                    8.5.3.4.3.2    Historical Trend (2016-2020)
                    8.5.3.4.3.3    Forecast Trend (2021-2026)
                8.5.3.4.4    DNA diagnostics
                    8.5.3.4.4.1    Market Share
                    8.5.3.4.4.2    Historical Trend (2016-2020)
                    8.5.3.4.4.3    Forecast Trend (2021-2026)
                8.5.3.4.5    Microarray
                    8.5.3.4.5.1    Market Share
                    8.5.3.4.5.2    Historical Trend (2016-2020)
                    8.5.3.4.5.3    Forecast Trend (2021-2026)
                8.5.3.4.6    Others
        8.5.4    Haematology
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2016-2020)
            8.5.4.3    Forecast Trend (2021-2026)
        8.5.5    Microbiology
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2016-2020)
            8.5.5.3    Forecast Trend (2021-2026)
        8.5.6    Coagulation and Haemostasis
            8.5.6.1    Market Share
            8.5.6.2    Historical Trend (2016-2020)
            8.5.6.3    Forecast Trend (2021-2026)
        8.5.7    Urinalysis
            8.5.7.1    Market Share
            8.5.7.2    Historical Trend (2016-2020)
            8.5.7.3    Forecast Trend (2021-2026)
        8.5.8    Others
    8.6    Global In-Vitro Diagnostics Market by Application
        8.6.1    Infectious Diseases
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Diabetes
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    Oncology
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
        8.6.4    Cardiology
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2016-2020)
            8.6.4.3    Forecast Trend (2021-2026)
        8.6.5    Drug Testing/Pharmacogenomics
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2016-2020)
            8.6.5.3    Forecast Trend (2021-2026)
        8.6.6    HIV/Aids
            8.6.6.1    Market Share
            8.6.6.2    Historical Trend (2016-2020)
            8.6.6.3    Forecast Trend (2021-2026)
        8.6.7    Autoimmune Diseases
            8.6.7.1    Market Share
            8.6.7.2    Historical Trend (2016-2020)
            8.6.7.3    Forecast Trend (2021-2026)
        8.6.8    Nephrology
            8.6.8.1    Market Share
            8.6.8.2    Historical Trend (2016-2020)
            8.6.8.3    Forecast Trend (2021-2026)
        8.6.9    Others
    8.7    Global In-Vitro Diagnostics Market by End Use
        8.7.1    Hospital and Clinics
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2016-2020)
            8.7.1.3    Forecast Trend (2021-2026)
        8.7.2    Diagnostic Laboratories
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2016-2020)
            8.7.2.3    Forecast Trend (2021-2026)
        8.7.3    Point-Of-Care Testing
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2016-2020)
            8.7.3.3    Forecast Trend (2021-2026)
        8.7.4    Academic Institutes
            8.7.4.1    Market Share
            8.7.4.2    Historical Trend (2016-2020)
            8.7.4.3    Forecast Trend (2021-2026)
        8.7.5    Others
    8.8    Global In-Vitro Diagnostics Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Danaher Corp
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    bioMérieux, Inc
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Siemens Healthcare GmbH
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    ARKRAY America, Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Sysmex Corporation
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    F. Hoffmann-La Roche Ltd
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Global In-Vitro Diagnostics Market: Key Industry Highlights, 2016 and 2026
2.    Global In-Vitro Diagnostics Historical Market: Breakup by Product and Service (USD Billion), 2016-2020
3.    Global In-Vitro Diagnostics Market Forecast: Breakup by Product and Service (USD Billion), 2021-2026
4.    Global In-Vitro Diagnostics Historical Market: Breakup by Technology (USD Billion), 2016-2020
5.    Global In-Vitro Diagnostics Market Forecast: Breakup by Technology (USD Billion), 2021-2026
6.    Global In-Vitro Diagnostics Historical Market: Breakup by Application (USD Billion), 2016-2020
7.    Global In-Vitro Diagnostics Market Forecast: Breakup by Application (USD Billion), 2021-2026
8.    Global In-Vitro Diagnostics Historical Market: Breakup by End Use (USD Billion), 2016-2020
9.    Global In-Vitro Diagnostics Market Forecast: Breakup by End Use (USD Billion), 2021-2026
10.    Global In-Vitro Diagnostics Historical Market: Breakup by Region (USD Billion), 2016-2020
11.    Global In-Vitro Diagnostics Market Forecast: Breakup by Region (USD Billion), 2021-2026
12.    North America In-Vitro Diagnostics Historical Market: Breakup by Country (USD Billion), 2016-2020
13.    North America In-Vitro Diagnostics Market Forecast: Breakup by Country (USD Billion), 2021-2026
14.    Europe In-Vitro Diagnostics Historical Market: Breakup by Country (USD Billion), 2016-2020
15.    Europe In-Vitro Diagnostics Market Forecast: Breakup by Country (USD Billion), 2021-2026
16.    Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by Country (USD Billion), 2016-2020
17.    Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by Country (USD Billion), 2021-2026
18.    Latin America In-Vitro Diagnostics Historical Market: Breakup by Country (USD Billion), 2016-2020
19.    Latin America In-Vitro Diagnostics Market Forecast: Breakup by Country (USD Billion), 2021-2026
20.    Middle East and Africa In-Vitro Diagnostics Historical Market: Breakup by Country (USD Billion), 2016-2020
21.    Middle East and Africa In-Vitro Diagnostics Market Forecast: Breakup by Country (USD Billion), 2021-2026
22.    Global In-Vitro Diagnostics Market Structure

Key Questions Answered in the Report

In 2020, the global in-vitro diagnostics market attained a value of nearly USD 63 billion.

The market is projected to grow at a CAGR of 4.5% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach USD 82 billion by 2026.

The major drivers of the market include rising population, growing urbanisation, increasing demand for advanced diagnostic facilities and shift towards rapid testing.

Technological advancements and the increasing focus on safety and accuracy are the key industry trends propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The product and service types include reagents and kits, instruments, and software and services.

The technological segments are immunodiagnostics, clinical chemistry, molecular diagnostics, haematology, microbiology, coagulation and haemostasis, and urinalysis, among others.

The diverse applications for market are infectious diseases, diabetes, oncology, cardiology, drug testing/pharmacogenomics, HIV/AIDS, autoimmune diseases, and nephrology, among others.

The end users for the industry consist of hospital and clinics, diagnostic laboratories, point-of-care testing, and academic institutes, among others.

The major players in the industry are Danaher Corp, bioMérieux, Inc., Siemens Healthcare GmbH, ARKRAY America, Inc., Sysmex Corporation, and F. Hoffmann-La Roche Ltd, among others.

Analyst Review

The global in-vitro diagnostics market attained a value of USD 63 billion in 2020, driven by the rising rapid testing. Aided by the growing technological advancements, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 4.5%. The market is projected to reach USD 82 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product and service types, the in-vitro diagnostics industry can be segmented into reagents and kits, instruments, and software and services. The classification based on technology are immunodiagnostics, clinical chemistry, molecular diagnostics, haematology, microbiology, coagulation, and haemostasis, and urinalysis, among others. On the basis of applications, the industry is divided into infectious diseases, diabetes, oncology, cardiology, drug testing/pharmacogenomics, HIV/AIDS, autoimmune diseases, and nephrology, among others. The end uses for the product include hospital and clinics, diagnostic laboratories, point-of-care testing, and academic institutes, among others. The major regional markets for in-vitro diagnostics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Danaher Corp, bioMérieux, Inc., Siemens Healthcare GmbH, ARKRAY America, Inc., Sysmex Corporation, and F. Hoffmann-La Roche Ltd, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER